Lucrin Depot 3.75mg Injection

Lucrin Depot Injection contains Leuprolide Acetate, a gonadotropin-releasing hormone (GnRH) agonist. It is used in the management of hormone-dependent conditions such as advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty (CPP). Lucrin lowers the production of certain hormones (testosterone in men, estrogen in women), controlling the growth of hormone-sensitive tissues and tumors.

• Lucrin Depot 3.75 mg Injection (monthly)
• Lucrin Depot 11.25 mg Injection (once every 3 months)

• Contains Leuprolide Acetate for hormone-dependent conditions
• Effective in advanced prostate cancer management
• Used in treatment of endometriosis and uterine fibroids
• Helps delay central precocious puberty (CPP) in children
• Long-acting depot formulation for sustained results

• Advanced prostate cancer in men
• Endometriosis and uterine fibroids in women
• Central precocious puberty (CPP) in children

• Administered intramuscularly by a healthcare professional
• 3.75 mg dose: once every month
• 11.25 mg dose: once every 3 months
• Dosage depends on patient’s medical condition and doctor’s recommendation

• Store below 25°C in a cool, dry place
• Protect from light and moisture
• Keep out of reach of children

• 100% genuine and quality-assured hormone therapy medicine
• Affordable pricing for 3.75 mg and 11.25 mg strengths
• Worldwide shipping with secure packaging
• Trusted supplier and exporter of specialty pharmaceuticals

Lucrin Depot Injection (Leuprolide Acetate) is a prescription-only medicine and must be administered strictly under the supervision of a qualified healthcare professional.